Lev5 — Class II medical device recall Z-1075-2025
Ongoing recall by Oxoid Limited, reported 2025-02-12, distributed in CA, FL, MA, NE, NH, VA, WA. Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Su
| Recall number | Z-1075-2025 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Oxoid Limited, Basingstoke, United Kingdom |
| Recall initiated | 2024-12-23 |
| Classified | 2025-02-04 |
| Reported by FDA | 2025-02-12 |
| Distributed | CA, FL, MA, NE, NH, VA, WA |
| Countries outside the US | AT, AU, BR, CA, CN, CR, DE, ES, FR, GB, GH, HK, ID, KR, NL, PE, PH, PL |
| Quantity | 1,406 units |
| Reason classes | labeling |
| UPC / GTIN / UDI-DI | 05032384079629 |
| Lot numbers | 6142394 |
| Model numbers | CT1587B |
Product
Lev5, REF CT1587B, 50 Susceptibility discs Levofloxacin 5 ug, IVD, CE 2797
Reason for recall
Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1075-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.